Mississippi Senate Bill SB2819

Mississippi 2023 Regular Session

• Introduced: 1/16/23
• Refer: 1/16/23
• Failed: 1/31/23

Caption

Screening & approval program for over-the-counter availability & retail sale of products; establish through Department of Health.

Impact

The bill empowers the State Health Officer to approve or deny the sale of these products based on various evidential bases, including anecdotal and scientific data. This represents a shift in state health policy, moving toward a more stringent regulatory approach to specific substances that might promote health risks among consumers. It also signifies a proactive measure to address substance abuse issues within communities by limiting access to potentially harmful products.

Summary

Senate Bill 2819 establishes a screening and approval program within the State Department of Health concerning the over-the-counter availability and retail sale of products that contain substances potentially used or abused recreationally. This program targets substances such as bath salts, kratom, and tianeptine. The main objective is to regulate these products to mitigate associated public health risks and to provide a framework for managing their sale in retail environments.

Contention

Potential points of contention may arise from manufacturers and distributors who are subjected to this regulatory framework, particularly those whose products are denied approval. The bill provides them an avenue to appeal to the State Board of Health if faced with a denial from the State Health Officer. Critics of such regulations might argue that they infringe upon consumer choice and the rights of businesses to operate freely, raising debates about the balance between public health safety and personal freedoms.